We do not support your browser. Please take a moment and upgrade to the most recent version of Internet Explorer.
CTSI Directory

Jane C. Deng, M.D. [ Edit Your Profile ]

Work Email Address: JDeng@mednet.ucla.edu

Lab Number: 310-983-3446
Office Phone Number: (310) 825-0617
Work Phone Number: (310) 825-8061

Office Address:
10833 Le Conte Ave.
BOX 951690, 37-131 CHS
Los Angeles, CA 90095

UCLA Associate Professor, Pulmonary and Critical Care Medicine Associate Professor, Medicine

Research Interests

Immunology - Immunoregulation, Immunology - Inflammation, Microbiology/Infectious Diseases - Pathogenesis of Infectious Diseases, Medicine - Pulmonary Diseases

M.S., University of California, Berkeley, 1992 - 1995
M.D., UC San Francisco School of Medicine, 1992 - 1997
2000 - 2004 University of Michigan Health System
1997 - 1998 University of Michigan Health System
1998 - 2000 University of Michigan Health System

2004 American Board of Internal Medicine
2003 American Board of Internal Medicine
2000 American Board of Internal Medicine


Dr. Jane Deng is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine, Department of Medicine. A California native, she is a graduate of the Joint Medical Program at UC-Berkeley and UC-San Francisco, where she earned her M.S. and M.D. degrees, respectively. She then did her residency training in Internal Medicine and fellowship in Pulmonary and Critical Care at the University of Michigan. She joined the faculty at UCLA in 2005. The Deng laboratory conducts research in the following areas: - Translational research in bacterial pneumonia and influenza infections. Specifically, we examine how the lung immune response to viral infections leads to increased risk of bacterial pneumonia. Collectively, influenza and bacterial pneumonia are the leading cause of death from infection in the U.S. and worldwide. - Epidemiology of infections in hospitalized patients. We have ongoing projects that are conducted by medical students and medical residents examining infectious complications of sepsis, liver failure, and respiratory viral infections. - Respiratory microbiome. In conjunction with the J. Craig Venter Institute, we are studying the human bacteriome and virome of the upper respiratory tract.

Yasir Tarabichi, M.D.; Kelvin Li, Ph.D.; Scott Hu, M.D., M.S.C.R.; Christopher Nguyen, M.D.; Xiaoyan Wang, Ph.D.; David A. Elashoff, Ph.D.; Kazima Saira, Ph.D.; Bryan Frank; Monika Bihan; Elodie Ghedin, Ph.D.; Barbara A Methé, Ph.D.; Jane C. Deng, M.D., M.S., The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles. Microbiome. 2015; .

Cite the Grant Number Trial Innovation Network Smart IRB